You are here: Industry Insights > Cancer

News List

Lengthy Viral Suppression May Cut Cancer Risk in HIV Infected drugs
June 12, 2018
Antiretroviral therapy resulting in long-term viral suppression of HIV may contribute to cancer prevention, according to a study published online June 12 in the Annals of Internal Medicine.
Sri Lanka to register two foreign cancer vaccines biospectrumasia
June 08, 2018
The Russian vaccine ‘Hearticad’ which was brought down by the minister was rejected by the Sri Lanka College of Oncologists.
DNA test may detect liver cancer europeanpharmaceuticalreview
June 08, 2018
A group of researchers have completed a phase II study comparing a set of DNA markers to alpha-fetoprotein as a method to test for liver cancer….
Janssen debuts promising new cancer data at ASCO pharmafile
June 07, 2018
Janssen took the opportunity at the American Society of Clinical Oncology (ASCO) annual event to present promising new Phase 2 and 3 data on two of its candidates
Trial to test cancer combo in both adults and children pharmatimes
June 06, 2018
UK researchers have launched an early stage trial designed to help assess whether AstraZeneca and MSD’s selumetinib could be effective in combination with dexamethasone as a treatment for leukaemia.
Ovarian cancer drug shows promise in pancreatic cancer patients with BRCA mutation worldpharmanews
June 05, 2018
A targeted therapy that has shown its power in fighting ovarian cancer in women including those with BRCA1 and BRCA2 mutations may also help patients with aggressive pancreatic cancer who harbor these mutations and have few or no other treatment options.
Tiny particles could help fight brain cancer worldpharmanews
June 05, 2018
Glioblastoma multiforme, a type of brain tumor, is one of the most difficult-to-treat cancers. Only a handful of drugs are approved to treat glioblastoma
Agendia and Angsana to Provide Breast Cancer Risk-of-Recurrence Testing with MammaPrint® and BluePrint® to Patients in Southeast Asia b3cnewswire.
June 04, 2018
Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, and Angsana Molecular & Diagnostics Laboratory Pte Ltd, a subsidiary of Parkway Pantai
Shuwen Biotech, Bliss pharma unite for companion diagnostics of cancer biospectrumasia
May 29, 2018
Companion diagnostics and precision medicine are Shuwen’s major focus
Merck's Keytruda, Roche's Tecentriq may lag chemo in some cancer patients, FDA says fiercepharma
May 23, 2018
Merck and Roche’s immunotherapies are each approved solo for certain previously untreated bladder cancer patients. But for other frontline patients, the drugs may be hurting their survival chances.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page